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Abstract: Aziridines are known to undergo hydrolysis in the presence of cyclodextrins, whereas the latter are 
largely  investigated  as  potential  vectors  of  biologically  active  compounds.  Despite  this  easy  cyclodextrin-
induced cleavage of aziridines in aqueous medium, it was of interest to find out a model aziridine derivative that 
would be sufficiently water-stable and form a stable complex with -cyclodextrin in aqueous medium, so that it 
could  be  used  as  a  reference  in  future  formulations  or  vectorization  work.    Among  compounds  we  have 
investigated,  we  found  out  that  only  (S)-2-isopropyl-1-(o-nitrophenyl)sulfonyl)aziridine  complied  with  the 
above-mentioned solubility and stability requirements.  NMR studies of the inclusion complex of this derivative 
with -cyclodextrin provided useful parameters related to the stoichiometry of the complex and the association 
constant  Ka.    The  geometry  of  the  complex  was  assessed  by  2D-ROESY  experiments,  suggesting  a  deep 
insertion of the aziridine into the cavity of -cyclodextrin. 
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Introduction   
 
Up to now, major interest in cyclodextrin (CDs) research has been fuelled by commercial 
targets,  and  many  of  the  published  reports  on  NMR  studies  about  interactions  of  small 
molecules  with  cyclodextrin  have  mainly  focused  on  pharmaceuticals
1.    This  is  because 
formulations with cyclodextrins proved to be efficient in providing a way to increase the 
solubility, the stability and/or other relevant physico-chemical properties of drugs at the same 
time
2.
 
Among three-membered heterocycles, aziridines form a group of natural and/or synthetic 
organic compounds that constitute a particularly versatile class of molecules as related both to 
their  chemical  reactivity  and  biological  properties
3,4.    We  focused  on  synthetic  sulfonyl 
aziridines, and we found that these compounds constituted a class of high interest because of 
their reactivity and biological activity
5.  Mediterr.J.Chem., 2014, 2(5),  A.  Keniche et al.  621 
 
 
Therefore, we explored the literature in order to find easily available compounds
6-10 that 
could allow us have an insight in the complexation of aziridines with -cyclodextrin.  
We  investigated  the  encapsulation  of  those  synthetic  derivatives  in  commercial-
cyclodextrin (CD), using NMR techniques with a view to establishing the stoichiometry of 
the complexes, calculating the association constant and determining some dynamic aspects of 
the complexation process
11.  It was of interest to find a model aziridine derivative that would 
withstand  the  induced  hydrolysis  catalysed  by  CD,  so  that  it  could  serve  in  future 
investigations related to formulation and transport of biologically active aziridines of interest 
within our laboratory 
12. 
A number of investigations can be found in the literature about CD complexes with 
different  compounds,  the  majority  being  of  pharmaceutical  interest
13.    The  results  and 
conclusions can hardly be extended to other classes of compounds, however. Thus, complexes 
of epoxides and N-tosylaziridines have been oxidised in the presence of 2-iodoxybenzoic acid 
in  water  by  Rao  and  co-workers  to  access  -hydroxyketones  and  -aminoketones
14. 
Previously, the same group also observed that cyclodextrins catalyse aziridine ring opening 
by means of supramolecular catalysis
15.  Other groups focused on modified cyclodextrin-
induced host-guests effects
16. An attempt to determine parameters of those complexes was 
made by Beijnen and co-workers, but resulted in the formation of amino-alcohols
 because of 
the CD-induced hydrolysis of aziridines
17.   
To the best of our knowledge, there are no previous studies about the encapsulation of N-
sulfonyl aziridines by cyclodextrins to provide complexes with accessible NMR and physico-
chemical characteristics, as those provided in this paper. In view of this, the major challenge 
to  us  was  to  prepare  an  aziridine  with  a  well-balanced  structural  compromise  between 
hydrophobic and hydrophilic groups in  order to  provide both  enough solubility and ring-
stability in water. In this work, we have used commercial -cyclodextrin (Fig.1) as a host 
model,  based  on  the  fact  that  its  internal  diameter  allowed  an  efficient  complexation  of 
medium-sized aromatic compounds and heterocyclic derivatives. 
 
 
 
Figure 1: Structure of -cyclodextrin. 
   
Therefore,  we  have  synthesized  some  known  sulfonyl  aziridines  according  to  the 
literature, and we have examined their potential to insert into CD.  It is worth mentioning 
that many synthetic schemes of aziridines can be found in the literature. We chose to perform 
our syntheses beginning from commercial chiral 1,2-amino alcohols
6,8b as shown in Scheme 1 
and in Table 1.  As a matter of fact, this procedure was rapid and straightforward, avoiding 
the tedious protection of amino alcohols.  What is more, it guaranteed the retention of the 
stereochemistry of the amino alcohol in the final aziridine
6a.  Besides, identification of our 
synthetic compounds could be easily checked for consistency with published data. 
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Scheme 1: Synthesis of aziridines 
 
Furthermore, we assumed that the stereochemistry of those known chiral aziridines could 
promote diastereomeric interactions with the CD glucopyranose unit stereocenters to ensure 
a unique inclusion pattern of guest compound versus the host.  
 
Table 1. Solubility and stability of aziridines (Az) in water: + stable / or soluble; -not 
soluble/or not stable/ Preparation references 
Az  R  R1  R2  Solubility  Stability 
minutes  References 
1  o-NO2  H  i-C3H7  +  120  5a 
2  p-NO2  H  i-C3H7  -  60  6 
3  p-Me  H  i-C3H7  -  30  7 
4  p-Me  H  Me  +  60  7b, 8 
5  p-NO2  H  Me  +  30  6a, 6c 
6  o-NO2  H  Me  +  30  9 
7  p- NO2  H  Ph  -  180  6a 
8  o- NO2  H  Ph  -  180  10 
 
Before the complexation studies, all of the compounds were checked for their stability in 
aqueous medium (Table 1), also because the complexation and transport of drugs in water is 
of interest in living organisms.  Therefore, a survey conducted in water would provide enough 
information for future formulation or studies in this field.  The stability of each complex was 
monitored by NMR analysis of an aliquot of the corresponding solution, carried out every five 
minutes, searching for the appearance of a hydroxyl signal in the region of 3-3.5ppm. When 
the latter was observed, this gave evidence for the opening of the aziridine.  
In the process of NMR spectroscopic assessment, the sampling time was shortened to two, 
then one minute in order to ensure the best accuracy possible.  As shown in Table 1, as far as 
stability was concerned, nitrobenzenesulfonyl-derivatives offered the best features. However, 
entries 1, 4, 5, and 6 are the more interesting  in terms of both   good water-stability and 
solubility in the presence of  CD, with the best overall pattern shown by entry 1.  Phenyl-
substituted  aziridines  offer  the  best  stability,  but  with  poor  solubility,  the  latter  being 
detrimental  to  their  selection  as  models.  Therefore,  only  (S)-2-isopropyl-1-(o-
nitrophenyl)sulfonyl)aziridine 1 (AZ1)
5 (Fig. 2) fulfilled all the above-mentioned criteria and 
was chosen as our model compound.  
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Figure 1: (S)-2-Isopropyl-1-(o-nitrophenyl)sulfonyl)aziridine 1 (AZ1). 
 
Results and Discussion  
 
Stoichiometry and binding constants 
Stoichiometry and binding constants are the usual quantitative descriptors of the binding 
of a guest compound to a host, and NMR techniques are routinely used to measure these 
parameters as far as guest-host complexes formation is concerned.  The terms of reference for 
such  studies  are  either  fast-exchange  or  slow-exchange  phenomena.  In  the  fast  exchange 
regime, which compares well with our work, the observed NMR frequencies are defined as 
the mole fraction weighted average between the frequencies in the native form and the bound 
form of the observed molecule.  For example, when the proton to be analysed is located on 
the host molecule, the chemical shift is given by the following equation: 
 
obs =XH XHGG 
 
Wherein  obs  is  the  chemical  shift  of  the  observed  nucleus  in  the  experiment,  H  the 
chemical shift of the unbound host molecule and HG is the chemical shift of the host in the 
complex. Besides, XH and XHG are the mole fractions of host molecule in the bound and the 
unbound states.  In this case, the analysis was more complicated than for the slow exchange 
regime, because the chemical shifts in the complex could not be observed.  This problem 
could be overcome by NMR titration, obtaining information on chemical shifts over a wide 
range of solutions of different compositions
18. 
One of the first  methods  used for the determination of the stoichiometry of inclusion 
complexes was Job’s method,
 also known as the continuous variation method
19,20.  For the 
experiment, we used stock solutions with equimolecular concentrations of Host (CD) and 
Guest (AZ1), according to the protocol of this method.  The samples were prepared by mixing 
various volumes of these solutions in such a way that the total concentration [CD] + [AZ1] 
remained constant and the molar fraction of AZ1, varied in the range from 0 to 1. Using NMR 
analysis,  the  experimental  data  for  the  characterization  of  complexes  were  the  observed 
variations of chemical shifts of both CD and AZ1
21.  
Therefore,  we  needed  an  accurate  identification  of  protons  that  were  sensitive  to 
complexation in order to determine the stoichiometry of the AZ1-CD complex.  The binding 
of AZ1 to CD was evidenced by a shielding of internal cyclodextrin H-3 and H-5 protons. 
The chemical shifts of the remaining H-1, H-2 and H-4 protons of the same host were not 
altered, as shown in Figure 3.  While this work was in progress, this behaviour was also 
observed  by  S.  Mashood  and  co-workers  in  their  structural  elucidation  of  CD-xylazine 
complex
22. 
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Figure 3: Expanded regions of
 1H NMR spectra (500 MHz, D2O): chemical shift variations  
of H-3, H-6, H-5, H-2 and H-4 protons of CD in the complex. 
 
This  selective  and  exclusive  effect  of  complexation  on  the  CD  internal  protons  is 
generally  taken  as  good  evidence  for  an  interaction,  where  AZ1  is  encapsulated  in  the 
hydrophobic core of the CD.  It can be attributed to the magnetic anisotropy associated with 
the  aromatic  ring  of  the  nitrophenyl  group  inside  the  hydrophobic  cavity  of  CD
21.    No 
distinct  chemical  shifts  were  observed  for  free  and  bound  states  of  the  host  and  guest 
molecules, but only one set of signals was found for each species when the AZ1/CD ratio 
was modified.  This observation was in good agreement with previously described systems 
regarding NMR fast-exchange limits
 23,24.  
The stoichiometry of the complex was determined by using the method of continuous 
variation
25,26.
  Chemical shifts differences for CD H-5 protons  were used to draw the plot, 
and the stoichiometry was determined by plotting ratios of CD.(CD H-5) against ratios 
of CD (Fig. 4) to afford a maximum at ratio CD = 0.5, which meant a 1:1 complex ratio 
between AZ1 and CD.  
The same result was provided when chemical shifts differences of CD H-3 were plotted 
against  molar  fractions  of  the  same  compound.    In  this  situation,  we  observed  that  the 
magnitude  of  (CD  H-5)  was  greater  than  (CD  H-3),  giving  evidence  for  a  deep 
inclusion of AZ1 inside the CD core. 
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Figure 4: Job’s Plot for the complex 
 
 
Calculation of Ka. 
The quantitative measurement of the complexation-induced shifts (CIS) of the AZ1-CD 
complex  at  25°C  is  represented  by  the  value  of  the  equilibrium  constant  governing  the 
formation of the inclusion complex (Table 2).   
There are many ways to calculate the value of Ka such as Graphical (or linearization) or 
Curve fitting methods. The first one was designed to produce a linear relationship between 
obs  and  Ka,  so  that  NMR  data  could  be  treated  graphically.    The  four  methods  Benesi-
Hildebrand’s (Hanna-Ashbaugh) treatment
27, Scatchard’s
 (Foster-Fyfe)
28, Scott’s plot
29 and 
Rose-Drago’s method
30 are well known for the graphical treatment of data.  Curve fitting 
methods do not require any approximation for the calculation of Ka. We used the CLAK 
program that allowed a good assessment of Ka (382 mol
–1)
31. 
 
Table 2: CIS = Observed increments induced on chemical shifts of CD H3 and H5 as a result 
of complexation with aziridine. CIS are related to concentrations of both CD and AZ1. 
CD (mmol)  mmol)  obsH3  obs H5 
7.89  0.0  0.0  0.0 
7.101  0.789  3.3  4.5 
6.312  1.578  10.8  14.6 
5.523  2.367  8.0  14.7 
4.734  3.156  11.4  21.7 
3.945  3.945  21.9  39.5 
3.156  4.734  24.8  43.5 
2.367  5.523  24.8  41.9 
1.578  6.312  26.4  41.6 
0.789  7.101  25.8  35.0 
 
 
The inclusion complex structure. 
One source of structural information might be the individual chemical shift modifications 
of protons of both guest and host.  This parameter is referred to as the complexation-induced 
shift, as already mentioned above (CIS, or ).  Therefore, modifications of chemical shifts of Mediterr.J.Chem., 2014, 2(5),  A.  Keniche et al.  626 
 
 
CD H-3 and H-5 protons provide good evidence for the formation of an internal AZ1-CD 
complex.  
More detailed information concerning the geometry of these inclusion complexes could be 
derived from the evidence of the spatial neighbourhood between AZ1 and CD protons.  This 
was achieved by investigating dipolar interactions using a 2D ROESY NMR experiment
32. 
This  technique  proved  to  be  the  most  sensitive  for  the  structural  analysis  of  inclusion 
complexes of CD formed in solutions
33. As was done in many other situations related to 
inclusion  complexes  in  water,
  a  300  milliseconds  (300  ms)  mixing  time  was  selected  to 
provide reliable dipolar cross-peaks with a minimal contribution of scalar transfer
34,35. 
The 2D-ROESY spectrum  of  the  AZ1/CD mixture (1:1) is  depicted in Figure 5a.  It 
shows strong 
1H-
1H cross peaks of the aromatic and aliphatic protons of AZ1 with CD H-3 
and/or H-5 protons.  These cross peaks along with the lack of correlation peaks with the 
protons on the outer-surface (H-2 and H-4), confirm the encapsulation of AZ1 inside the 
cavity of CD. 
 
 
Figure 2a. Partial contour plots of ROESY experiment (mixing time: 300 ms, 500 MHz); 
inclusion complex CD-AZ1 (5
 mmol
-1) in D2O, at 298 °K: areas of Az1 aliphatic (a) and 
aromatic protons (b). 
 
The 2D spectrum showed several intermolecular cross-peaks between CD H-3 and H-5 
protons and protons of the aromatic ring of (nitrophenyl)sulfonyl group of AZ1 (H1’, H2’, 
H3’and H4’), giving evidence for the inclusion of this group inside the hydrophobic cavity 
(Figure 5b). Mediterr.J.Chem., 2014, 2(5),  A.  Keniche et al.  627 
 
 
 
 
Figure 3b. Partial contour plots of ROESY experiment (500 MHz, mixing time: 300 ms), 
inclusion complex CD/AZ1 (5
 mM
-1) in D2O, at 298K: areas of aliphatic protons (a) and 
aromatic protons (b) of aziridine. 
 
Additional dipolar correlations were found between protons on the aziridine ring (Hb, Hd 
and Hc) with CD H-3 and H-5 protons.  Finally, methyl protons presented a correlation only 
with the CD H-3 proton.  This could accounted for by the spatial vicinity of this section of 
the aziridine with the (nitrophenyl)sulfonyl group, confirming that AZ1 is deeply inserted into 
the  cavity  of  CD  by  means  of  its  (nitrophenyl)sulfonyl  group.    We  also  observed 
intermolecular cross peaks only with the inner CD protons, and this observation established 
intracavity binding without giving evidence for outside contributions.  
Therefore, and taking into account the attributions of the NMR analysis, we suggest the 
following geometry for the structure of our complex (Fig. 6). 
 
Figure 6: Proposed structure for the inclusion complex AZ1-CD. 
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Conclusion 
 
We have carried out the first NMR complexation study between a stable aziridine and 
CD.  The stoichiometry and association constant were determined by Job’s method and 
CLAK program.  The spatial relationship between CD and AZ1 was assessed using ROESY 
experiments.  Furthermore,  NMR  studies  provided  evidence  that  the  interaction  was  an 
inclusion phenomenon, but not an association phenomenon, since the changes obtained for 
CD signals involved protons that were oriented towards the cavity of the host molecule. 
The way  parameters were determined in  this  work can serve for future investigations 
related not only to design new aziridines of biological interest, but also to formulation of 
existing aziridine-containing drugs. 
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Experimental Section  
 
All the reactions needing anhydrous conditions were performed with dry solvents and 
carried  out  under  nitrogen.    Solvents  were  purified  and  dried  according  to  standard 
procedures. Reagents for synthesis were used as received. I.R spectra were collected from a 
Mattson Genesis II FTIR. NMR spectra were recorded at 25 
°C in CDCl3 (0.004mmol.L
-1) on 
a Bruker 500, 400 or 300 MHz instrument,  using tetramethylsilane (TMS) as  an internal 
standard.  Chemical shifts are given in  (ppm) and coupling constant (J) values in Hertz 
(Hz). ROESY spectra were recorded using 500 ms mixing times and computer processing was 
performed using Mestrenova Software (version 6.2). Column chromatography was performed 
on silica gel 230-270 mesh (Merck) using CH2Cl2, MeOH or mixture of both according to thin 
layer chromatography (TLC) results.  
 
Preparation of aziridines. 
 
General procedure 
Tosyl-,  p-Nitrobenzensulfonyl-  or  o-Nitrobenzensulfonyl  chloride  (0.799g,  3.60  mmol) 
was added in one portion to a suspension of (S)-amino alcohol (0.124g, 1.20 mmol) in dry 2:1 
CH2Cl2/pyridine (3mL)  at 0 °C, and the resulting mixture was stirred at room temperature for 
4 - 6h.  The mixture was then diluted with CH2Cl2 (30 mL) and washed with 2 M HCl (3×12 
mL). The aqueous layer was extracted with CH2Cl2 (20 mL), and the organic portions were 
combined  and  carefully  shaken  (CAUTION:  an  undesirable  emulsion  is  produced  under 
vigorous shaking) with 2M KOH aqueous solution (6×30 mL) and the aqueous layer was 
extracted with CH2Cl2 (20 mL). The organic layer was dried over MgSO4 and the solvent was 
removed to afford aziridines.  Purification was carried out by column chromatography, using 
CH2Cl2  according  to  previous  TLC  results.    The  optical  purity  was  retained  in  the  final 
product and elemental analysis matched those of the literature. 
(S)-2-isopropyl-1-(o-nitrophenyl)sulfonyl)aziridine 1 (from L-valinol). 
(CAS registry number 111 0273-57-8).  
Yield 90%, yellow oil, solidifying on standing: mp 64 °C. []D
20 = + 12.0 (c = 1.0 CHCl3).   
Rf  = 0.5 (CH2Cl2), IR(cm
-1) film: 1540(S=O), 1360(S–O), 1175(C–O), 950(Ph). 
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(500 MHz, CDCl3)  0.84(d, J = 6.7Hz, 3H, CH3), 0.88(d, J = 6.9Hz, 3H, CH3), 1.50(m, 2H, 
H-3), 1.59(m, 1H, H-2) 1,98(m, 1H, CHMe2), 7.68 (m, 1H, Ph), 8.02(m, 1H, Ph), 8.14(m, 1H, 
Ph), 8.52(m, 1H, Ph). 
13C NMR (126 MHz, CDCl3) δ 18.66 (CH3), 35.12(CH), 37.98(N-C3), 
47.26(N-C2),  124.16(C-Ph),  128.10(C-Ph),  131.12(C-Ph),  131.86(C-Ph),  134.33(C-SO2-), 
147.18(C-NO2). Elemental analysis: calcd for C11H14N2SO4, C 48.8; H 5.2; N 10.4. Found C 
49.0; H 5.1; N 10.2. 
(S)-2-isopropyl-1-(p-nitrophenyl)sulfonyl)aziridine 2 (from L-valinol). 
White solid; mp 74 °C; Rf= 0.50 (CH2Cl2) []D
20 = +11.2 (c =1.0 CHCl3). 
1H NMR (300 
MHz, CDCl3)  0.85(d, J = 6.9Hz, 3H, CH3), 0.94(d, J = 7.0Hz, 3H, CH3), 1.39-1.53(m, 1H, 
CHMe2), 2.16-2.23(m, 1H, H-Az), 2.64-2.76(m, 2H, NC2-H, H-Az), 8.16(d, J = 9.0Hz, 2H, 
Ar-H),  8.38(d,  J  =  9.0Hz,  2H,  Ar-H). 
13C  NMR  (126  MHz,  CDCl3)  δ  19.5(CH3), 
30.1(CHMe2), 33.6(Az-C3), 47.0(Az-C2), 124.2(Ar-C3), 129.3(Ar-C2), 144.1(Ar-C-SO2-), 
150.6(Ar-C-NO2).. Elemental analysis: calcd for C11H14N2SO4, C 48.9; H 5.3; N 10.3. Found 
C 49.0; H 5.2; N 10.4. 
(S)-2-isopropyl-1-Tosylaziridine 3 (from L-valinol). 
1H NMR (300 MHz, CDCl3) 0.80(d, J = 6.9Hz, 3H, CH3), 0.90(d, J = 6.8Hz, 3H, CH3), 
1.37-1.46(m,  1H,  CHMe2),  2.43(s,  3H,  H3C-Ar),  2.49-2.56(m,  1H,  Az-H1),  2.62(d,  J  = 
7.0Hz, 1H, ), 7.33(d, J  = 8.1Hz, 2H, Ar-H), 7.85(d, J = 8.1Hz, 2H, Ar-H). ). 
13C NMR 
(126MHz,  CDCl3)    19.5(CH3),  21.4(CH3-Ar),  30.0(CHMe2),  32.9(Az-C3),  46.2(Az-C2), 
128.0(Ar-C2), 129.7(Ar-C3), 135.0(Ar-C-CH3), 144.5(Ar-C-SO2-). Elemental analysis: calcd 
for C12H17NSO2: C 60.3; H 7.2; N 5.9. Found C 60.4; H 7.1; H 5.8. 
(S)-2-methyl-1-tosylaziridine 4 (from L-alaninol). 
Transparent liquid. Rf = 0.58 (CH2Cl2/MeOH 9:1). 
1H NMR (400 MHz, CDCl3) 1.20(d, J = 
6.8Hz, 3H, CH3), 2.09(d, J= 5.8Hz, 1H, Az-H), 2.44(s, 3H, CH3), 2.62(d, J = 6.9Hz, 1H, Az-
H), 2.79(ddq, J = 7.0, 6.0, 5.0Hz, 1H, NCHMe),  7.34(d, J = 8.3Hz, 2H, Ar-H), 7.83(d, J = 
8.3Hz, 2H, Ar-H). 
13C NMR (126 MHz, CDCl3) δ 19.8(Ar-CH3), 21.5(CH3), 34.7(Az-C2), 
36.1(Az-C3), 127.9(Ar-C2), 129.8(Ar-C3), 135.1(Ar-C-CH3), 144.6(Ar-C-SO2-). Elemental 
analysis: calcd for C10H13NSO2: C 56.9; H 6.2; N 6.6. Found C 57.0; H 6.3; N 6.5 
(S)-2-methyl-1-(p-nitrophenyl)sulfonyl)aziridine 5 (from L-alaninol). 
White  solid;  mp  87  °C,  []D
20  =  +  24.5  (c  =  1.0  CHCl3). 
1H  NMR  (300  MHz,  CDCl3) 
d J = 6.0Hz, 3H, CH3), 2.13(d, J = 5.0Hz, 1H, Az-H), 2.75(d, J = 7.0Hz, 1H, Az-H), 
2.89-3.05(m, 1H, NC2-H), 8.15(d, J = 8.9Hz, 2H, Ar-H), 8.39(d, J = 8.9Hz, 2H, Ar-H). 
13C 
NMR  (126  MHz,  CDCl3)  δ  19.4  CH3),  36.1(CH2N),  125.1(Ar-C-3),  130.9(Ar-C-2), 
143.9(Ar-C-SO2-), 146.4(Ar-C-NO2). Elemental analysis: calcd for C9H10N2SO4 C 44.6; H 
4.1; N 11.6. Found: C 44.8; H 4.0, N 11.7. 
(S)-2-methyl-1-(o-nitrophenyl)sulfonyl)aziridine 6 (from L-alaninol). 
Oil. 
1H NMR (300 MHz, CDCl3) 1.32(d, J = 5.6Hz, 3H, CH3), 2.83(d, J = 7.0Hz, Az-CH2), 
3.00-3.04(m,  1H,  Az-CHMe),  7.68-8.25(m,  4H,  Ar-H). 
13C  NMR  (126  MHz,  CDCl3)  δ 
20.1(CH3),  24.0(Az-C2),  38.1(Az-C3),  125.1(C-CNO2),  130.0(Ar-C6),  132.9(Ar–C4), 
134.2(Ar-C1), 136.9(Ar-C5), 146.4(Ar-C-NO2). Elemental analysis: calcd for C9H10N2SO4 C 
44.6; H 4.1; N 11.6. Found: C 44.7; H 4.2, N 115. 
(S)-1-((p-nitrophenyl)sulfonyl)-2-phenylaziridine 7 (from L-(+)--phenylglycinol). 
White  solid;  mp  121°C,  []D
20=  +  77.9  (c  =  1.0  CHCl3). 
1H  NMR  (300  MHz,  CDCl3) 
d, J= 5Hz, 1H, Az-H), 3.09(d, J = 7.0Hz, 1H, Az-H), 3.89(dd,J = 7.1, 4.7Hz, 1H, N-
CH), 7.19-7.39(m, 5H, Ph), 8.20(d, J = 9.0Hz, 2H, Ar-H), 8.39(d, J = 9.0Hz, 2H, Ar-H). 
13C 
NMR  (126  MHz,  CDCl3)  δ  36.6(Az-C3),  41.9(Az-C2),  124.4(Ph-C4),  127.7(Ar-C2), 
127.9(Ph-C2), 128.3(Ph-C3), 129.2(Ar-C3), 144.0(Ar-C-SO2-), 150.6(Ar-C-NO2). Elemental 
analysis: calcd for C14H12N2SO4. C 55.3; H 3.9; N 9.2. Found C 55.2; H 4.0; N 9.3. 
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(S)-1-((o-nitrophenyl)sulfonyl)-2-phenylaziridine 8 (from L-(+)--phenylglycinol). 
 
1H NMR (300 MHz, CDCl3)  2.51(d, J= 5.0 Hz, 1H, NCH), 3.11(d, J= 7.0Hz, 1H, Az-H), 
3.92(d,  J=5Hz,  1H,  Az-H),  5.30(m,  5H,  Ph),  7.68-8.2(m,  4H,  Ar). 
13C  NMR  (126  MHz, 
CDCl3)    37.64(Az-C3),  42.83(Az-C2),  124.23(Ar-C3),  126.47(Ph-C4),  127.5(Ph-C2), 
128.1(Ar-C6), 128.61(Ph-C3), 130.85(Ar-C4), 131.93(Ar-C5), 134.19(Ar-CSO2-), 148.57Ar-
CNO2). Elemental analysis: calcd for C14H12N2SO4. C 55.3; H 3.9; N 9.2. Found C 55.0; H 
4.1; N 9.5. 
 
 Inclusion procedure: aziridine 1- CD. 
Solutions for NMR titration were prepared by mixing 7.89 mM mother solutions of AZ1 
and CD to provide a series of solutions with a ratio ranging from 1 to 0.  The solutions to be 
analyzed were kept  at  a constant  concentration (7.89  mM) with  a total  volume steady at 
500µl.  This solution was sonicated for 10 min and subsequently analyzed by NMR. All NMR 
data were collected at 25 °C on a Bruker 500 MHz. The 2D data were obtained with a flip 
angle  (90°  pulse  =  9.7  μs),  and  acquisition  time  of  16  s  and  a  relaxation  delay  of  1s. 
Conditions for 
1H NMR data were flip angle (90° pulse = 9.7 μs), acquisition time (AT) = 4 s, 
numbers of scans (NS) = 16 and a relaxation delay of 1s. 
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